Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1994-09

AUTHORS

Steven A. Curley, Robert A. Newman, Thomas B. Dougherty, George M. Fuhrman, Diana L. Stone, Jeffrey A. Mikolajek, Sal Guercio, Ann Guercio, C. Humberto Carrasco, M. Tien Kuo, David C. Hohn

ABSTRACT

Background: We performed a phase I study of a novel system of complete hepatic venous isolation and extracorporeal chemofiltration in patients with unresectable hepatocellular carcinoma (HCC) to determine (a) whether systemic exposure to doxorubicin could be limited after high-dose hepatic arterial infusion (HAI), and (b) the hepatic maximum tolerated dose (MTD) of doxorubicin.Methods: Ten patients with biopsy-proven HCC were treated with 20-min HAI of doxorubicin (17 total treatments). Two patients were treated with doxorubicin 60 mg/m2, three patients were treated at 90 mg/m2, and five patients received 120 mg/m2. A newly developed dual-balloon vena cava catheter was advanced from the femoral vein, and the balloons were inflated to isolate and capture total hepatic venous outflow. The hepatic venous blood was pumped through extracorporeal carbon chemofilters before return of the blood to the systemic circulation.Results: Peak systemic doxorubicin levels were an average 85.6% lower than were peak prefilter levels (p<0.01). Because all catheters were placed percutaneously and because the chemofiltration markedly limited systemic chemotherapy exposure, patients were discharged 1 day after 16 of the 17 treatments. The hepatic and systemic MTD of doxorubicin in this treatment protocol was 120 mg/m2.Conclusions: This novel system of complete hepatic venous isolation and chemofiltration limits systemic chemotherapy toxicity and will allow use of higher doses of chemotherapeutic agents to treat HCC. More... »

PAGES

389-399

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf02303811

DOI

http://dx.doi.org/10.1007/bf02303811

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052604918

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7850540


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catheterization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Cancer, Regional Perfusion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemofiltration", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatic Veins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intra-Arterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Circulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Complications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vena Cava Filters", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Curley", 
        "givenName": "Steven A.", 
        "id": "sg:person.011321563157.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011321563157.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Investigations, University of Texas M. D. Anderson Cancer Center, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Clinical Investigations, University of Texas M. D. Anderson Cancer Center, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Newman", 
        "givenName": "Robert A.", 
        "id": "sg:person.015001751152.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015001751152.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology, University of Texas M. D. Anderson Cancer Center, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Anesthesiology, University of Texas M. D. Anderson Cancer Center, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dougherty", 
        "givenName": "Thomas B.", 
        "id": "sg:person.01102453456.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102453456.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fuhrman", 
        "givenName": "George M.", 
        "id": "sg:person.01017757260.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017757260.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Investigations, University of Texas M. D. Anderson Cancer Center, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Clinical Investigations, University of Texas M. D. Anderson Cancer Center, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stone", 
        "givenName": "Diana L.", 
        "id": "sg:person.01272771574.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272771574.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology, University of Texas M. D. Anderson Cancer Center, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Anesthesiology, University of Texas M. D. Anderson Cancer Center, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mikolajek", 
        "givenName": "Jeffrey A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiac Perfusion, Texas Heart Institute, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.416986.4", 
          "name": [
            "Department of Cardiac Perfusion, Texas Heart Institute, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guercio", 
        "givenName": "Sal", 
        "id": "sg:person.0763764316.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763764316.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiac Perfusion, Texas Heart Institute, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.416986.4", 
          "name": [
            "Department of Cardiac Perfusion, Texas Heart Institute, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guercio", 
        "givenName": "Ann", 
        "id": "sg:person.01032077516.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032077516.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carrasco", 
        "givenName": "C. Humberto", 
        "id": "sg:person.0661361305.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661361305.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuo", 
        "givenName": "M. Tien", 
        "id": "sg:person.010730616217.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010730616217.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hohn", 
        "givenName": "David C.", 
        "id": "sg:person.0633536712.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633536712.76"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00252979", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047938674", 
          "https://doi.org/10.1007/bf00252979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046872608", 
          "https://doi.org/10.1007/bf00686224"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1994-09", 
    "datePublishedReg": "1994-09-01", 
    "description": "Background: We performed a phase I study of a novel system of complete hepatic venous isolation and extracorporeal chemofiltration in patients with unresectable hepatocellular carcinoma (HCC) to determine (a) whether systemic exposure to doxorubicin could be limited after high-dose hepatic arterial infusion (HAI), and (b) the hepatic maximum tolerated dose (MTD) of doxorubicin.Methods: Ten patients with biopsy-proven HCC were treated with 20-min HAI of doxorubicin (17 total treatments). Two patients were treated with doxorubicin 60 mg/m2, three patients were treated at 90 mg/m2, and five patients received 120 mg/m2. A newly developed dual-balloon vena cava catheter was advanced from the femoral vein, and the balloons were inflated to isolate and capture total hepatic venous outflow. The hepatic venous blood was pumped through extracorporeal carbon chemofilters before return of the blood to the systemic circulation.Results: Peak systemic doxorubicin levels were an average 85.6% lower than were peak prefilter levels (p<0.01). Because all catheters were placed percutaneously and because the chemofiltration markedly limited systemic chemotherapy exposure, patients were discharged 1 day after 16 of the 17 treatments. The hepatic and systemic MTD of doxorubicin in this treatment protocol was 120 mg/m2.Conclusions: This novel system of complete hepatic venous isolation and chemofiltration limits systemic chemotherapy toxicity and will allow use of higher doses of chemotherapeutic agents to treat HCC.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf02303811", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "1"
      }
    ], 
    "keywords": [
      "hepatic venous isolation", 
      "complete hepatic venous isolation", 
      "hepatocellular carcinoma", 
      "extracorporeal chemofiltration", 
      "total hepatic venous outflow", 
      "biopsy-proven hepatocellular carcinoma", 
      "phase I", 
      "systemic chemotherapy toxicity", 
      "hepatic arterial infusion", 
      "hepatic venous outflow", 
      "unresectable hepatocellular carcinoma", 
      "hepatic venous blood", 
      "dose of doxorubicin", 
      "vena cava catheter", 
      "human hepatocellular carcinoma", 
      "chemotherapy toxicity", 
      "chemotherapy exposure", 
      "arterial infusion", 
      "systemic exposure", 
      "femoral vein", 
      "venous outflow", 
      "venous blood", 
      "doxorubicin levels", 
      "treatment protocol", 
      "systemic circulation", 
      "patients", 
      "high doses", 
      "chemotherapeutic agents", 
      "chemofiltration", 
      "doxorubicin", 
      "carcinoma", 
      "catheter", 
      "blood", 
      "treatment", 
      "exposure", 
      "infusion", 
      "MTD", 
      "dose", 
      "doses", 
      "vein", 
      "levels", 
      "balloon", 
      "m2", 
      "toxicity", 
      "days", 
      "isolation", 
      "agents", 
      "circulation", 
      "Chemofilter", 
      "protocol", 
      "novel system", 
      "use", 
      "outflow", 
      "return", 
      "system", 
      "maximum"
    ], 
    "name": "Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study", 
    "pagination": "389-399", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052604918"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf02303811"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7850540"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf02303811", 
      "https://app.dimensions.ai/details/publication/pub.1052604918"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_219.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf02303811"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02303811'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02303811'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02303811'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02303811'


 

This table displays all metadata directly associated to this object as RDF triples.

289 TRIPLES      21 PREDICATES      105 URIs      95 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf02303811 schema:about N0e09a8b20768432c8599906e580b9509
2 N1ad40362fa894f509cd1016fc97eaf7f
3 N2d00bd9fbd7e4197be3b8f90b6878b10
4 N33a9dbd948514a4fbfdf8313f3cb9283
5 N34314b1578274465af292a58003b6311
6 N4138bf8cd93549a088e7c7f6a9a4ccd5
7 N42d3e7ac139945749b702d74444cde6d
8 N44d43a4e10a24747914b6ea046e56f2a
9 N49b9620c229a40548fd2497c0858af3e
10 N6a2b770674cf4412a55121c8e7dca26f
11 N6eecca04111841d5ac957d183b879993
12 N7b741c87bb604d479ee9caa2e0c00e98
13 N8e0b06161dc34eabb28d26510794a01c
14 N9ab27e8241204d62864f0479548a76d4
15 Na917f319c0c54041b4eb2a5461859b1b
16 Nb410d03ff1b148aa95647a1bfc7e45d5
17 Nb63ce727a4a643538dcb950b58a8d361
18 Nb7fb0385a8bc43678c37fbc551989d4b
19 Nbe0c57636f2c41999b36168e1e758416
20 Nca99ce2d6e2341eca297e9be6e2e11aa
21 Nf12b56ae10bf49f884eb9f03e7dbbb24
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author N287b2f8a1fe94104a135a89947db459a
25 schema:citation sg:pub.10.1007/bf00252979
26 sg:pub.10.1007/bf00686224
27 schema:datePublished 1994-09
28 schema:datePublishedReg 1994-09-01
29 schema:description Background: We performed a phase I study of a novel system of complete hepatic venous isolation and extracorporeal chemofiltration in patients with unresectable hepatocellular carcinoma (HCC) to determine (a) whether systemic exposure to doxorubicin could be limited after high-dose hepatic arterial infusion (HAI), and (b) the hepatic maximum tolerated dose (MTD) of doxorubicin.Methods: Ten patients with biopsy-proven HCC were treated with 20-min HAI of doxorubicin (17 total treatments). Two patients were treated with doxorubicin 60 mg/m2, three patients were treated at 90 mg/m2, and five patients received 120 mg/m2. A newly developed dual-balloon vena cava catheter was advanced from the femoral vein, and the balloons were inflated to isolate and capture total hepatic venous outflow. The hepatic venous blood was pumped through extracorporeal carbon chemofilters before return of the blood to the systemic circulation.Results: Peak systemic doxorubicin levels were an average 85.6% lower than were peak prefilter levels (p<0.01). Because all catheters were placed percutaneously and because the chemofiltration markedly limited systemic chemotherapy exposure, patients were discharged 1 day after 16 of the 17 treatments. The hepatic and systemic MTD of doxorubicin in this treatment protocol was 120 mg/m2.Conclusions: This novel system of complete hepatic venous isolation and chemofiltration limits systemic chemotherapy toxicity and will allow use of higher doses of chemotherapeutic agents to treat HCC.
30 schema:genre article
31 schema:isAccessibleForFree false
32 schema:isPartOf N0f793b26a6d74235ba82c6fc530914a2
33 Ne0d316677e014ab79b5e53406d9417a3
34 sg:journal.1105545
35 schema:keywords Chemofilter
36 MTD
37 agents
38 arterial infusion
39 balloon
40 biopsy-proven hepatocellular carcinoma
41 blood
42 carcinoma
43 catheter
44 chemofiltration
45 chemotherapeutic agents
46 chemotherapy exposure
47 chemotherapy toxicity
48 circulation
49 complete hepatic venous isolation
50 days
51 dose
52 dose of doxorubicin
53 doses
54 doxorubicin
55 doxorubicin levels
56 exposure
57 extracorporeal chemofiltration
58 femoral vein
59 hepatic arterial infusion
60 hepatic venous blood
61 hepatic venous isolation
62 hepatic venous outflow
63 hepatocellular carcinoma
64 high doses
65 human hepatocellular carcinoma
66 infusion
67 isolation
68 levels
69 m2
70 maximum
71 novel system
72 outflow
73 patients
74 phase I
75 protocol
76 return
77 system
78 systemic chemotherapy toxicity
79 systemic circulation
80 systemic exposure
81 total hepatic venous outflow
82 toxicity
83 treatment
84 treatment protocol
85 unresectable hepatocellular carcinoma
86 use
87 vein
88 vena cava catheter
89 venous blood
90 venous outflow
91 schema:name Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study
92 schema:pagination 389-399
93 schema:productId N219671239401465ba211047fb3d6a565
94 N3e75d8dce6044b1eb43b870d87921a93
95 Nf220a2f497704701a472ecb1ff17a36a
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052604918
97 https://doi.org/10.1007/bf02303811
98 schema:sdDatePublished 2022-11-24T20:47
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher N0c3ea3e7926f41dd813017f693e60743
101 schema:url https://doi.org/10.1007/bf02303811
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N04feb52c09324d03b139ca8f6f26ea9a rdf:first sg:person.01017757260.77
106 rdf:rest N084aff7f497a4aa282fb1fedc1f099cc
107 N084aff7f497a4aa282fb1fedc1f099cc rdf:first sg:person.01272771574.64
108 rdf:rest N8c056b510e164a52be9d635aa12ba8c8
109 N0c3ea3e7926f41dd813017f693e60743 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N0e09a8b20768432c8599906e580b9509 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Aged
113 rdf:type schema:DefinedTerm
114 N0f793b26a6d74235ba82c6fc530914a2 schema:volumeNumber 1
115 rdf:type schema:PublicationVolume
116 N1ad40362fa894f509cd1016fc97eaf7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Infusions, Intra-Arterial
118 rdf:type schema:DefinedTerm
119 N219671239401465ba211047fb3d6a565 schema:name doi
120 schema:value 10.1007/bf02303811
121 rdf:type schema:PropertyValue
122 N232a644d66664e139e9e634413bccdd2 rdf:first sg:person.0763764316.41
123 rdf:rest Ne85f1212dd404320b4856036ef989d88
124 N287b2f8a1fe94104a135a89947db459a rdf:first sg:person.011321563157.26
125 rdf:rest Nefb896a284f94a75bc20637792fcc2a3
126 N2d00bd9fbd7e4197be3b8f90b6878b10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Hemofiltration
128 rdf:type schema:DefinedTerm
129 N2fc30f0971824426b0a40d0e7f1308d2 schema:affiliation grid-institutes:grid.240145.6
130 schema:familyName Mikolajek
131 schema:givenName Jeffrey A.
132 rdf:type schema:Person
133 N33a9dbd948514a4fbfdf8313f3cb9283 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Doxorubicin
135 rdf:type schema:DefinedTerm
136 N34314b1578274465af292a58003b6311 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Female
138 rdf:type schema:DefinedTerm
139 N3e75d8dce6044b1eb43b870d87921a93 schema:name pubmed_id
140 schema:value 7850540
141 rdf:type schema:PropertyValue
142 N4138bf8cd93549a088e7c7f6a9a4ccd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Carcinoma, Hepatocellular
144 rdf:type schema:DefinedTerm
145 N42d3e7ac139945749b702d74444cde6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Humans
147 rdf:type schema:DefinedTerm
148 N44d43a4e10a24747914b6ea046e56f2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Chemotherapy, Cancer, Regional Perfusion
150 rdf:type schema:DefinedTerm
151 N49b9620c229a40548fd2497c0858af3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Male
153 rdf:type schema:DefinedTerm
154 N4af8a2b39e3b4cb68a40f1b53277a5a9 rdf:first sg:person.01102453456.05
155 rdf:rest N04feb52c09324d03b139ca8f6f26ea9a
156 N6a2b770674cf4412a55121c8e7dca26f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 N6eecca04111841d5ac957d183b879993 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Time Factors
161 rdf:type schema:DefinedTerm
162 N7b741c87bb604d479ee9caa2e0c00e98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Dose-Response Relationship, Drug
164 rdf:type schema:DefinedTerm
165 N8c056b510e164a52be9d635aa12ba8c8 rdf:first N2fc30f0971824426b0a40d0e7f1308d2
166 rdf:rest N232a644d66664e139e9e634413bccdd2
167 N8e0b06161dc34eabb28d26510794a01c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Adult
169 rdf:type schema:DefinedTerm
170 N9ab27e8241204d62864f0479548a76d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Liver Circulation
172 rdf:type schema:DefinedTerm
173 Na917f319c0c54041b4eb2a5461859b1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Vena Cava Filters
175 rdf:type schema:DefinedTerm
176 Nb2f29743e8334cae8ff664381389f516 rdf:first sg:person.0633536712.76
177 rdf:rest rdf:nil
178 Nb410d03ff1b148aa95647a1bfc7e45d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Liver Neoplasms
180 rdf:type schema:DefinedTerm
181 Nb564746c8f0945d8b257fdb64b4f3770 rdf:first sg:person.010730616217.44
182 rdf:rest Nb2f29743e8334cae8ff664381389f516
183 Nb63ce727a4a643538dcb950b58a8d361 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Combined Modality Therapy
185 rdf:type schema:DefinedTerm
186 Nb7fb0385a8bc43678c37fbc551989d4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Catheterization
188 rdf:type schema:DefinedTerm
189 Nbe0c57636f2c41999b36168e1e758416 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Hemodynamics
191 rdf:type schema:DefinedTerm
192 Nca99ce2d6e2341eca297e9be6e2e11aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Postoperative Complications
194 rdf:type schema:DefinedTerm
195 Nd9091445ada6495b84266aaf4f98eed9 rdf:first sg:person.0661361305.23
196 rdf:rest Nb564746c8f0945d8b257fdb64b4f3770
197 Ne0d316677e014ab79b5e53406d9417a3 schema:issueNumber 5
198 rdf:type schema:PublicationIssue
199 Ne85f1212dd404320b4856036ef989d88 rdf:first sg:person.01032077516.49
200 rdf:rest Nd9091445ada6495b84266aaf4f98eed9
201 Nefb896a284f94a75bc20637792fcc2a3 rdf:first sg:person.015001751152.06
202 rdf:rest N4af8a2b39e3b4cb68a40f1b53277a5a9
203 Nf12b56ae10bf49f884eb9f03e7dbbb24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Hepatic Veins
205 rdf:type schema:DefinedTerm
206 Nf220a2f497704701a472ecb1ff17a36a schema:name dimensions_id
207 schema:value pub.1052604918
208 rdf:type schema:PropertyValue
209 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
210 schema:name Medical and Health Sciences
211 rdf:type schema:DefinedTerm
212 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
213 schema:name Clinical Sciences
214 rdf:type schema:DefinedTerm
215 sg:journal.1105545 schema:issn 1068-9265
216 1534-4681
217 schema:name Annals of Surgical Oncology
218 schema:publisher Springer Nature
219 rdf:type schema:Periodical
220 sg:person.01017757260.77 schema:affiliation grid-institutes:grid.240145.6
221 schema:familyName Fuhrman
222 schema:givenName George M.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017757260.77
224 rdf:type schema:Person
225 sg:person.01032077516.49 schema:affiliation grid-institutes:grid.416986.4
226 schema:familyName Guercio
227 schema:givenName Ann
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032077516.49
229 rdf:type schema:Person
230 sg:person.010730616217.44 schema:affiliation grid-institutes:grid.240145.6
231 schema:familyName Kuo
232 schema:givenName M. Tien
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010730616217.44
234 rdf:type schema:Person
235 sg:person.01102453456.05 schema:affiliation grid-institutes:grid.240145.6
236 schema:familyName Dougherty
237 schema:givenName Thomas B.
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102453456.05
239 rdf:type schema:Person
240 sg:person.011321563157.26 schema:affiliation grid-institutes:grid.240145.6
241 schema:familyName Curley
242 schema:givenName Steven A.
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011321563157.26
244 rdf:type schema:Person
245 sg:person.01272771574.64 schema:affiliation grid-institutes:grid.240145.6
246 schema:familyName Stone
247 schema:givenName Diana L.
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272771574.64
249 rdf:type schema:Person
250 sg:person.015001751152.06 schema:affiliation grid-institutes:grid.240145.6
251 schema:familyName Newman
252 schema:givenName Robert A.
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015001751152.06
254 rdf:type schema:Person
255 sg:person.0633536712.76 schema:affiliation grid-institutes:grid.240145.6
256 schema:familyName Hohn
257 schema:givenName David C.
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633536712.76
259 rdf:type schema:Person
260 sg:person.0661361305.23 schema:affiliation grid-institutes:grid.240145.6
261 schema:familyName Carrasco
262 schema:givenName C. Humberto
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661361305.23
264 rdf:type schema:Person
265 sg:person.0763764316.41 schema:affiliation grid-institutes:grid.416986.4
266 schema:familyName Guercio
267 schema:givenName Sal
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763764316.41
269 rdf:type schema:Person
270 sg:pub.10.1007/bf00252979 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047938674
271 https://doi.org/10.1007/bf00252979
272 rdf:type schema:CreativeWork
273 sg:pub.10.1007/bf00686224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046872608
274 https://doi.org/10.1007/bf00686224
275 rdf:type schema:CreativeWork
276 grid-institutes:grid.240145.6 schema:alternateName Department of Anesthesiology, University of Texas M. D. Anderson Cancer Center, USA
277 Department of Clinical Investigations, University of Texas M. D. Anderson Cancer Center, USA
278 Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, USA
279 Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, USA
280 Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA
281 schema:name Department of Anesthesiology, University of Texas M. D. Anderson Cancer Center, USA
282 Department of Clinical Investigations, University of Texas M. D. Anderson Cancer Center, USA
283 Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, USA
284 Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, USA
285 Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA
286 rdf:type schema:Organization
287 grid-institutes:grid.416986.4 schema:alternateName Department of Cardiac Perfusion, Texas Heart Institute, Houston, Texas, USA
288 schema:name Department of Cardiac Perfusion, Texas Heart Institute, Houston, Texas, USA
289 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...